Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

« Back

Document Details

Filing Date
Jun 7, 2019
Document Date
Jul 25, 2019
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon